Diclofenac Transdermal Patch and Parnaparin: Interaction Details

Brand names
Diclofenac Transdermal Patch
Flector PatchLicart Topical SystemZorvolex +12 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Diclofenac Transdermal Patch and Parnaparin interaction:

Share

Share this interaction

Diclofenac Transdermal Patch

Brand names
  • Flector Patch
  • Licart Topical System
  • Zorvolex
  • Pennsaid
  • Licart
  • Aleve Arthritis Pain
  • Lofena
  • Xiclo
  • Flector
  • Voltaren
  • Cataflam
  • Zipsor
  • Cambia
  • diclofenac epolamine
  • Diclox Patch 30CT

Parnaparin

We don't have a drug information page for Parnaparin yet. Have a question about Parnaparin? Ask a pharmacist, free →

What Happens When You Take Diclofenac Transdermal Patch With Parnaparin

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving together with heparinoids or low-molecular-weight heparins (LMWH) can raise the likelihood of major bleeding, which includes spinal or epidural hematomas in individuals undergoing spinal puncture or receiving neuraxial anesthesia. Where feasible, the should be stopped before LMWH therapy is started.2 When an NSAID and an LMWH must be used concurrently, exercise extreme caution and monitor the patient closely for any signs and symptoms of bleeding.1

The Diclofenac Transdermal Patch and Parnaparin Interaction, Explained

You're using a diclofenac patch (Flector, Licart, or Xiclo) for pain, and parnaparin, a given by injection to help prevent clots. Diclofenac is an , a pain reliever that can make your (the tiny cells that help blood clot) work less well. Parnaparin slows down your body's clotting system. Together, they can raise your chance of bleeding, even though the patch puts less medicine into your blood than a pill.

Watch for unusual bruising, nosebleeds, bleeding gums, black or bloody stools, or blood in your urine. If you are having a spinal or epidural procedure, tell your team about both medicines. Don't stop anything on your own. Your care team can manage this safely by checking on you more closely.

Interaction: Topical diclofenac () + parnaparin (LMWH) produce an increase in bleeding risk. Diclofenac inhibits COX-1-mediated thromboxane A2 synthesis and can injure the mucosa. Parnaparin potentiates antithrombin against factor Xa (and IIa to a lesser degree). There is no relevant PK interaction. Systemic exposure from the patch is low, but the risk is not eliminated.

  • Severity: major. Evidence: probable. Onset: unspecified.
  • There is a risk of major bleeding, including epidural or spinal hematoma, with neuraxial anesthesia or spinal puncture.
  • Management: Discontinue the NSAID before starting the LMWH when possible. If is required, use extreme caution and closely monitor for signs and symptoms of bleeding (clinical bleeding, Hgb/Hct, GI bleeding, and neurologic deficits after neuraxial procedures).

See the 6 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Diclofenac Transdermal Patch and Parnaparin Interact

The likely mechanism

Decreased function; decreased coagulation

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Diclofenac Transdermal Patch and Parnaparin Interaction

Your care team has a few ways to keep you safe here:

  • When possible, they may decide to stop the diclofenac patch before you begin parnaparin.
  • If you need both, they will use extra caution and monitor you more closely for bleeding.
  • If you have a spinal or epidural procedure planned, they will take both medicines into account.

What you can do: Keep using both exactly as prescribed unless your prescriber tells you otherwise. Make sure your pharmacist and every doctor know about the patch. Report any unusual bleeding or bruising, black stools, or new back pain, numbness, or leg weakness right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Diclofenac Transdermal Patch or Parnaparin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Epidural hematoma in an ambulatory surgical patient

    A woman aged 60 years whose medications included aspirin, naproxen, nifedipine, captopril, cimetidine, and potassium supplements was scheduled to undergo ambulatory arthroscopic lateral meniscectomy. She was given 30 mg of a low-molecular-weight heparin 90 minutes before epidural anesthesia was started.

    The operation proceeded without complication, and she was sent home with intact motor and sensory function. Roughly 2 hours afterward, she developed severe lumbar back pain and came back to the hospital 90 minutes later, at which point motor function in her lower extremities had been lost.

    An epidural hematoma was identified on computerized tomography and was then evacuated in emergency surgery. Full motor and sensory function had returned by the second postoperative day. While aspirin, , and low-molecular-weight heparin are each regarded as safe when given individually before neuraxial block, the combined use of all 3 agents in this patient was believed to have led to the epidural hematoma.3

  2. Report 2 · Study title

    Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?

    To evaluate whether of enoxaparin and ketorolac can cause excessive postoperative bleeding, 60 patients having total hip replacement surgery were randomly assigned to 2 groups. Any previous therapy was stopped 4 weeks prior to surgery.

    Every patient was given enoxaparin 40 mg subcutaneously 12 hours before surgery and then once daily for 10 days. In addition, 26 patients received ketorolac 30 mg intramuscularly at of anesthesia followed by 30 mg once daily for 4 days.

    The remaining 34 patients were given enoxaparin together with and acetaminophen analgesia. The groups did not differ significantly in intraoperative blood loss, postoperative drainage, transfusion requirements, wound oozing, bruising, or leg swelling.

    Furthermore, clinically detectable did not occur in any patient. The authors proposed that the likelihood of increased bleeding from combined use of a low-molecular-weight heparin and an NSAID is low, as long as the NSAID dose is modest.4

  3. Report 3 · Study title

    Increased blood loss after preoperative NSAID

    In a retrospective study of patients receiving enoxaparin during hip replacement surgery, those who had used before surgery showed significantly greater perioperative blood loss and more frequent use of blood transfusions than those who had not taken NSAIDs preoperatively. Postoperative blood loss did not differ between the 2 groups.5

  4. Report 4 · Study title

    Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis

    In a double-blind, placebo-controlled, randomized, crossover study intended to evaluate the hemostatic interaction between ketorolac and dalteparin, 24 healthy male volunteers aged 18 to 55 years received each of the 4 combinations of ketorolac/placebo and dalteparin/placebo. Ketorolac inhibited aggregation in whole blood and in platelet-rich plasma and, as a result, prolonged skin bleeding time.

    Following dalteparin administration, antifactor Xa levels rose significantly and the activated partial thromboplastin time was prolonged, although values stayed within the range of the normal population. Ketorolac and dalteparin interacted to prolong bleeding time, whereas dalteparin by itself did not affect bleeding time. complications may potentially arise perioperatively when dalteparin and ketorolac are given together.6

Diclofenac Transdermal Patch and Parnaparin: Common Questions

How serious is the Diclofenac Transdermal Patch and Parnaparin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Diclofenac Transdermal Patch and Parnaparin interaction managed?

Your care team has a few ways to keep you safe here: When possible, they may decide to stop the diclofenac patch before you begin parnaparin. If you need both, they will use extra caution and monitor you more closely for bleeding. If you have a spinal or epidural procedure planned, they will take both medicines into account. What you can do: Keep using both exactly as prescribed unless your prescr… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Diclofenac Transdermal Patch and Parnaparin Interaction

Ask in your own words about taking Diclofenac Transdermal Patch and Parnaparin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (6)

  1. Product Information: SPRIX(TM) nasal spray, ketorolac tromethamine nasal spray. Roxro Pharma, Inc, Menlo Park, CA, 2009. DailyMed
  2. Product Information: Lovenox(R) subcutaneous injection, intravenous injection, enoxaparin sodium subcutaneous injection, intravenous injection. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  3. Porterfield WR & Wu CL: Epidural hematoma in an ambulatory surgical patient. J Clin Anesth 1997; 9:74-76. PubMed
  4. Weale AE, Warwick DJ, Durant N, et al: Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?. Ann R Coll Surg Engl 1995; 77:35-37.
  5. Fauno P, Petersen KD, & Husted SE: Increased blood loss after preoperative NSAID. Acta Orthop Scand 1993; 64:522-524.
  6. Greer IA, Gibson JL, Young A, et al: Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis. Blood Coagul Fibrinolysis 1999; 10:367-373. PubMed
Was this write-up helpful?

Other Serious Interactions of Diclofenac Transdermal Patch and Parnaparin

Also serious with Diclofenac Transdermal Patch

Also serious with Parnaparin

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.